ACL

Alcon Inc. (NYSE:ALC) is a Swiss-headquartered eye care company that was spun off from Novartis and went public in 2019. Founded in 1945, Alcon has grown to become one of the world's largest dedicated eye care companies, focusing exclusively on developing, manufacturing, and distributing products for eye care professionals and their patients globally. The company operates through two primary business segments: Surgical and Vision Care, serving ophthalmologists, optometrists, and consumers worldwide with a comprehensive portfolio of eye care solutions.